The abstract is read at the publisher; the summary is JClub's.
Mosaic hemagglutinin influenza B mRNA-LNP vaccination in non-human primates induced high binding antibody titers against antigenically distant strains, with strong hemagglutination inhibition and ADCC activity.
- Why it matters: Influenza B causes about one-third of annual infections, and current vaccines show only moderate effectiveness against matched strains, motivating more broadly protective options.
- What they did: Non-human primates received influenza B cHA or mHA mRNA-LNPs, and immunogenicity was compared with a quadrivalent seasonal influenza vaccine.
- The result: mHA mRNA-LNPs generated antibodies linked to significant hemagglutination inhibition and antibody-dependent cellular cytotoxicity, and the serum provided protection in mice in a serum transfer challenge.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.